FDA Inspection 1171206 — Nexus Pharmaceuticals, LLC
The FDA completed an inspection of Nexus Pharmaceuticals, LLC on May 25, 2022 in Lincolnshire, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 25, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lincolnshire, IL (United States)